Finally, we demonstrated the increased expression of S100A4 also in fibroblasts derived from amyotrophic lateral sclerosis (ALS) patients carrying SOD1 pathogenic variants. This evidence concerns the gene S100A4 and amyotrophic lateral sclerosis.